Total Payments
$78,690
2024 Payments
$1,091
Companies
30
Transactions
174
Medicare Patients
3,036
Medicare Billing
$245,909
Payment Breakdown by Category
Other$57,040 (72.5%)
Consulting$8,735 (11.1%)
Travel$5,203 (6.6%)
Food & Beverage$4,850 (6.2%)
Research$2,826 (3.6%)
Education$36.62 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $57,040 | 38 | 72.5% |
| Consulting Fee | $8,735 | 5 | 11.1% |
| Travel and Lodging | $5,203 | 13 | 6.6% |
| Food and Beverage | $4,850 | 113 | 6.2% |
| Unspecified | $2,826 | 2 | 3.6% |
| Education | $36.62 | 3 | 0.0% |
Payments by Type
General
$75,864
172 transactions
Research
$2,826
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $47,319 | 77 | $0 (2024) |
| Genentech USA, Inc. | $22,589 | 32 | $0 (2020) |
| Genentech, Inc. | $3,430 | 5 | $0 (2018) |
| F. Hoffmann-La Roche AG | $2,826 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharma GmbH & Co.KG | $1,335 | 2 | $0 (2017) |
| GlaxoSmithKline, LLC. | $292.93 | 13 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $158.57 | 2 | $0 (2019) |
| Mallinckrodt Enterprises LLC | $125.98 | 6 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $83.75 | 5 | $0 (2024) |
| Insmed, Inc. | $74.36 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,091 | 10 | Boehringer Ingelheim Pharmaceuticals, Inc. ($933.64) |
| 2023 | $2,915 | 6 | F. Hoffmann-La Roche AG ($2,826) |
| 2022 | $507.93 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($490.96) |
| 2021 | $9,236 | 12 | Boehringer Ingelheim Pharmaceuticals, Inc. ($9,167) |
| 2020 | $5,297 | 16 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,235) |
| 2019 | $19,840 | 42 | Boehringer Ingelheim Pharmaceuticals, Inc. ($10,575) |
| 2018 | $16,886 | 51 | Genentech USA, Inc. ($7,126) |
| 2017 | $22,916 | 33 | Boehringer Ingelheim Pharmaceuticals, Inc. ($14,848) |
All Payment Transactions
174 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $31.81 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $634.93 | General |
| Category: RESPIRATORY | ||||||
| 06/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: VACCINES | ||||||
| 06/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $298.71 | General |
| Category: RESPIRATORY | ||||||
| 05/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: IMMUNOLOGY | ||||||
| 02/12/2024 | Resmed Corp | AIRSENSE (Device) | Food and Beverage | Cash or cash equivalent | $16.85 | General |
| Category: Sleep | ||||||
| 01/31/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Respiratory | ||||||
| 01/18/2024 | PFIZER INC. | CUTAQUIG (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: IMMUNOLOGY | ||||||
| 01/08/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 11/30/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Respiratory | ||||||
| 10/27/2023 | Resmed Corp | myAir (Device) | Food and Beverage | Cash or cash equivalent | $14.55 | General |
| Category: Sleep | ||||||
| 07/06/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: Respiratory | ||||||
| 06/30/2023 | F. Hoffmann-La Roche AG | Esbriet (Biological) | — | In-kind items and services | $1,996.00 | Research |
| Study: Factors Associated with Persistence with Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis Enrolled in the Pulmonary Fibrosis Foundation Patient Registry • Category: Immunology | ||||||
| 05/15/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Respiratory | ||||||
| 03/31/2023 | F. Hoffmann-La Roche AG | Esbriet (Biological) | — | In-kind items and services | $829.60 | Research |
| Study: Factors Associated with Persistence with Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis Enrolled in the Pulmonary Fibrosis Foundation Patient Registry • Category: Immunology | ||||||
| 09/28/2022 | Inogen, Inc. | InogenOne (Device) | Food and Beverage | Cash or cash equivalent | $2.24 | General |
| Category: Oxygen Concentrator | ||||||
| 09/23/2022 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: NEUROLOGY | ||||||
| 05/17/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $463.42 | General |
| Category: RESPIRATORY | ||||||
| 04/04/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Education | In-kind items and services | $27.54 | General |
| Category: RESPIRATORY | ||||||
| 12/28/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $2,179.85 | General |
| Category: RESPIRATORY | ||||||
| 11/03/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $204.30 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $2,064.70 | General |
| Category: RESPIRATORY | ||||||
| 07/22/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: RESPIRATORY | ||||||
| 05/17/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Factors Associated with Persistence with Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis Enrolled in the Pulmonary Fibrosis Foundation Patient Registry | F. Hoffmann-La Roche AG | $2,826 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 647 | 1,019 | $226,586 | $52,514 |
| 2022 | 14 | 747 | 1,005 | $231,869 | $55,762 |
| 2021 | 16 | 888 | 1,365 | $316,255 | $76,384 |
| 2020 | 13 | 754 | 1,090 | $265,391 | $61,250 |
Total Patients
3,036
Total Services
4,479
Medicare Billing
$245,909
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 88 | $32,560 | $8,090 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 123 | $31,119 | $7,740 | 24.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 49 | $24,304 | $6,713 | 27.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 91 | 158 | $29,862 | $6,437 | 21.6% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 90 | 159 | $29,256 | $6,021 | 20.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 44 | 52 | $18,460 | $4,901 | 26.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 27 | 27 | $19,035 | $4,494 | 23.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 81 | 149 | $17,433 | $3,538 | 20.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 93 | 164 | $19,844 | $3,070 | 15.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 11 | 11 | $2,409 | $791.23 | 32.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $684.00 | $366.24 | 53.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 13 | 27 | $1,620 | $353.80 | 21.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 55 | 66 | $32,736 | $8,817 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 97 | 138 | $34,914 | $8,718 | 25.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 81 | 104 | $36,920 | $8,212 | 22.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 86 | 123 | $23,247 | $5,645 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 52 | $19,240 | $5,021 | 26.1% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 79 | 112 | $20,608 | $4,800 | 23.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 22 | 22 | $15,510 | $3,678 | 23.7% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 89 | 121 | $14,157 | $3,151 | 22.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 91 | 129 | $15,609 | $2,650 | 17.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $9,674 | $2,223 | 23.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 22 | 22 | $4,818 | $1,505 | 31.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 25 | 25 | $1,425 | $735.60 | 51.6% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 20 | 40 | $2,160 | $498.26 | 23.1% |
About Dr. Amy Case, MD
Dr. Amy Case, MD is a Pulmonary Disease healthcare provider based in Austell, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1467664466.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Case, MD has received a total of $78,690 in payments from pharmaceutical and medical device companies, with $1,091 received in 2024. These payments were reported across 174 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($57,040).
As a Medicare-enrolled provider, Case has provided services to 3,036 Medicare beneficiaries, totaling 4,479 services with total Medicare billing of $245,909. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine, Internal Medicine
- Location Austell, GA
- Active Since 05/04/2007
- Last Updated 11/23/2015
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1467664466
Products in Payments
- OFEV (Drug) $38,911
- Esbriet (Biological) $28,220
- TRELEGY ELLIPTA (Drug) $181.99
- ACTHAR (Biological) $142.90
- OPSUMIT (Drug) $110.13
- BREO (Drug) $81.02
- Arikayce (Drug) $74.36
- UPTRAVI (Drug) $48.44
- FASENRA (Biological) $42.83
- Adempas (Drug) $42.44
- SPIRIVA RESPIMAT (Drug) $34.22
- Xhance (Drug) $33.64
- XARELTO (Drug) $32.38
- YUPELRI (Drug) $31.81
- NUCALA (Biological) $29.92
- XYWAV (Drug) $28.06
- Flexitouch Plus (Device) $25.79
- Pulmonx Endobronchial Valve EBV (Device) $23.92
- UTIBRON (Drug) $21.87
- STIOLTO RESPIMAT (Drug) $17.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Austell
Chad Miller, Md, MD
Pulmonary Disease — Payments: $453,344
Pulmonary Disease $453,344
Dr. Steven Harris, M.d, M.D
Pulmonary Disease — Payments: $63,956
Pulmonary Disease $63,956
Dr. Sriram Paramesh
Pulmonary Disease — Payments: $16,528
Pulmonary Disease $16,528
Dr. Aristidis Iatridis, M.d, M.D
Pulmonary Disease — Payments: $9,041
Pulmonary Disease $9,041
Dr. Samuel Szumstein, M.d, M.D
Pulmonary Disease — Payments: $8,893
Pulmonary Disease $8,893
Dr. Stuart Simon, M.d, M.D
Pulmonary Disease — Payments: $2,993
Pulmonary Disease $2,993